IW U.S. 500: Top Biotechnology and Pharmaceutical Companies (slideshow)

Oct. 12, 2023
The largest producers of drugs and gene therapies and the tools that support the life sciences from the IW U.S. 500 list of largest publicly traded manufacturing companies in the country.

While not as dominant as oil and gas producers, pharmaceutical and biotechnology manufacturers had fantastic results in 2022, driven in some cases by COVID-19 vaccines and by general growth in others.

After having been shut out of the 2022 IW U.S. 500 list of America’s largest publicly traded manufacturers, a major pharmaceutical company took the No. 10 spot this year, leapfrogging a rival that placed No. 11.

As a group, the bio-pharma industry grew revenues by 6.5% in 2022 and achieved a 20% profit margin, earning $133.7 billion on $667.6 billion in sales. For details on how the Top 10 companies in the space performed, please browse through the slideshow.

2023 IW U.S. 500 Coverage

About the Author

Robert Schoenberger


LinkedIn: linkedin.com/in/robert-schoenberger-4326b810

Bio: Robert Schoenberger has been writing about manufacturing technology in one form or another since the late 1990s. He began his career in newspapers in South Texas and has worked for The Clarion-Ledger in Jackson, Mississippi; The Courier-Journal in Louisville, Kentucky; and The Plain Dealer in Cleveland where he spent more than six years as the automotive reporter. In 2014, he launched Today's Motor Vehicles (now EV Manufacturing & Design), a magazine focusing on design and manufacturing topics within the automotive and commercial truck worlds. He joined IndustryWeek in late 2021.

Sponsored Recommendations

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!